Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Splenic neoplasm malignancy unspecified
ADR ID BADD_A10956
ADR Hierarchy
01      Blood and lymphatic system disorders
01.13      Haematopoietic neoplasms (excl leukaemias and lymphomas)
01.13.01      Haematologic neoplasms NEC
01.13.01.007      Splenic neoplasm malignancy unspecified
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.21      Haematopoietic neoplasms (excl leukaemias and lymphomas)
16.21.01      Haematologic neoplasms NEC
16.21.01.007      Splenic neoplasm malignancy unspecified
Description Tumors or cancer of the SPLEEN. [MeSH]
MedDRA Code 10053190
MeSH ID D013160
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Splenic neoplasm | Splenic neoplasm malignancy unspecified | Splenic Neoplasms | Neoplasm, Splenic | Splenic Neoplasm | Neoplasms, Splenic | Spleen Neoplasms | Neoplasm, Spleen | Neoplasms, Spleen | Spleen Neoplasm | Cancer of Spleen | Spleen Cancers | Splenic Cancer | Cancer, Splenic | Cancers, Splenic | Splenic Cancers | Cancer of the Spleen | Spleen Cancer | Cancer, Spleen | Cancers, Spleen
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01913Ranitidine0.000088%
The 1th Page    1    Total 1 Pages